Symptomatic management and new therapeutic directions in Lesch‑Nyhan syndrome (Review)
- Authors:
- Drishti Valechha
- Charmi Jyotishi
- Mansi Patel
- Reeshu Gupta
-
Affiliations: Parul Institute of Applied Sciences, Parul University, Vadodara, Gujarat 391760, India - Published online on: March 5, 2025 https://doi.org/10.3892/wasj.2025.331
- Article Number: 43
-
Copyright : © Valechha et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Cheppalli V and Nikhilesh A: A review on lesch-nyhan syndrome: A rare inherited disorder with hypoxanthine-guanine phosphoribosyltransferase deficiency. Int J Pharm Sci Rev Res. 78:92–99. 2023. | |
|
Reisz JA, Dzieciatkowska M, Stephenson D, Gamboni F, Morton DH and D'Alessandro A: Red blood cells from individuals with Lesch-Nyhan syndrome: Multi-omics insights into a novel S162N mutation causing Hypoxanthine-guanine phosphoribosyltransferase deficiency. Antioxidants (Basel). 12(1699)2023.PubMed/NCBI View Article : Google Scholar | |
|
Nanagiri A and Shabbir N: Lesch-nyhan syndrome: In: StatPearls. StatPearls Publishing, Treasure Island, FL, 2024. | |
|
Torres RJ and Puig JG: Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis. 2(48)2007.PubMed/NCBI View Article : Google Scholar | |
|
Baumeister AA and Frye GD: The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome. Neurosci Biobehav Rev. 9:169–178. 1985.PubMed/NCBI View Article : Google Scholar | |
|
Wurtele SK, King AC and Drabman RS: Treatment package to reduce SIB in a Lesch-Nyhan patient. J Ment Defic Res. 28:227–234. 1984.PubMed/NCBI View Article : Google Scholar | |
|
Momosaki K, Kido J, Matsumoto S, Taniguchi A, Akiyama T, Sawada T, Ozasa S and Nakamura K: The Effect of S-Adenosylmethionine treatment on neurobehavioral phenotypes in Lesch-Nyhan disease: A case report. Case Rep Neurol. 11:256–264. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Christie R, Bay C, Kaufman IA, Bakay B, Borden M and Nyhan WL: Lesch-Nyhan disease: Clinical experience with nineteen patients. Dev Med Child Neurol. 24:293–306. 1982.PubMed/NCBI View Article : Google Scholar | |
|
Sampat R, Fu R, Larovere LE, Torres RJ, Ceballos-Picot I, Fischbach M, de Kremer R, Schretlen DJ, Puig JG and Jinnah HA: Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants. Hum Genet. 129:71–78. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Camici M, Micheli V, Ipata PL and Tozzi MG: Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem Int. 56:367–378. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Fu R, Sutcliffe D, Zhao H, Huang X, Schretlen DJ, Benkovic S and Jinnah HA: Clinical severity in Lesch-Nyhan disease: The role of residual enzyme and compensatory pathways. Mol Genet Metab. 114:55–61. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cakmakli HF, Torres RJ, Menendez A, Yalcin-Cakmakli G, Porter CC, Puig JG and Jinnah HA: Macrocytic anemia in Lesch-Nyhan disease and its variants. Genet Med. 21:353–360. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Nyhan WL: Clinical features of the Lesch-nyhan syndrome. Arch Intern Med. 130:186–192. 1972.PubMed/NCBI | |
|
Del Bene VA, Crawford JL, Gomez-Gastiasoro A, Vannorsdall TD, Buchholz A, Ojeda N, Harris JC, Jinnah HA and Schretlen DJ: Microstructural white matter abnormalities in Lesch-Nyhan disease. Eur J Neurosci. 55:264–276. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Schretlen DJ, Varvaris M, Ho TE, Vannorsdall TD, Gordon B, Harris JC and Jinnah HA: Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: A cross-sectional study. Lancet Neurol. 12:1151–1158. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Fasullo M and Endres L: Nucleotide salvage deficiencies, DNA damage and neurodegeneration. Int J Mol Sci. 16:9431–9449. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Krajewski O, Opielka M, Urbanowicz K, Chojnowski K, Kochany P, Pawlowski K, Tomaszewska J, Peters GJ, Smoleński RT and Bełdzińska MM: Management of neurological symptoms in Lesch-Nyhan disease: A systematic review. Neurosci Biobehav Rev. 165(105847)2024.PubMed/NCBI View Article : Google Scholar | |
|
Visser JE, Bar PR and Jinnah HA: Lesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev. 32:449–475. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Olson L and Houlihan D: A review of behavioral treatments used for Lesch-Nyhan syndrome. Behav Modif. 24:202–222. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Jang G, Shin HR, Do HS, Kweon J, Hwang S, Kim S, Heo SH, Kim Y and Lee BH: Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing. Mol Ther Nucleic Acids. 31:586–595. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Fu R, Ceballos-Picot I, Torres RJ, Larovere LE, Yamada Y, Nguyen KV, Hegde M, Visser JE, Schretlen DJ, Nyhan WL, et al: Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain. 137:1282–1303. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Ceballos-Picot I, Le Dantec A, Brassier A, Jais JP, Ledroit M, Cahu J, Ea HK, Daignan-Fornier B and Pinson B: New biomarkers for early diagnosis of Lesch-Nyhan disease revealed by metabolic analysis on a large cohort of patients. Orphanet J Rare Dis. 10(7)2015.PubMed/NCBI View Article : Google Scholar | |
|
Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Ceballos-Picot I, Gonzalez-Alegre P, Neychev V, Torres RJ, Dulac O, et al: Delineation of the motor disorder of Lesch-Nyhan disease. Brain. 129:1201–1217. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Vinokurov AY, Soldatov VO, Seregina ES, Dolgikh AI, Tagunov PA, Dunaev AV, Skorkina MY, Deykin AV and Abramov AY: HPRT1 deficiency induces alteration of mitochondrial energy metabolism in the brain. Mol Neurobiol. 60:3147–3157. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Jinnah HA, Ceballos-Picot I, Torres RJ, Visser JE, Schretlen DJ, Verdu A, Laróvere LE, Chen CJ, Cossu A, Wu CH, et al: Attenuated variants of Lesch-Nyhan disease. Brain. 133:671–689. 2010.PubMed/NCBI View Article : Google Scholar | |
|
ThinkGenetic Foundation: Lesch-nyhan syndrome. https://thinkgenetic.org/diseases/lesch-nyhan-syndrome/. Accessed July 17, 2024. | |
|
Mak BS, Chi CS, Tsai CR, Lee WJ and Lin HY: New mutations of the HPRT gene in Lesch-Nyhan syndrome. Pediatr Neurol. 23:332–335. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Nguyen KV, Naviaux RK and Nyhan WL: Novel mutation in the human HPRT1 gene and the Lesch-Nyhan disease. Nucleosides Nucleotides Nucleic Acids. 36:704–711. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang D, Zhao J, Teng J, Li W, Zhao X and Li L: Genetic analysis of a Chinese pedigree with Lesch-Nyhan syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 40:723–726. 2023.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Li L, Qiao X, Liu F, Wang J, Shen H, Fu H and Mao JH: Description of the molecular and phenotypic spectrum of Lesch-nyhan disease in eight chinese patients. Front Genet. 13(868942)2022.PubMed/NCBI View Article : Google Scholar | |
|
Ogasawara N, Stout JT, Goto H, Sonta S, Matsumoto A and Caskey CT: Molecular analysis of a female Lesch-Nyhan patient. J Clin Invest. 84:1024–1027. 1989.PubMed/NCBI View Article : Google Scholar | |
|
van Bogaert P, Ceballos I, Desguerre I, Telvi L, Kamoun P and Ponsot G: Lesch-Nyhan syndrome in a girl. J Inherit Metab Dis. 15:790–791. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Yukawa T, Akazawa H, Miyake Y, Takahashi Y, Nagao H and Takeda E: A female patient with Lesch-Nyhan syndrome. Dev Med Child Neurol. 34:543–546. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Yamada Y, Goto H, Yukawa T, Akazawa H and Ogasawara N: Molecular mechanisms of the second female Lesch-Nyhan patient. Adv Exp Med Biol. 370:337–340. 1994.PubMed/NCBI View Article : Google Scholar | |
|
De Gregorio L, Nyhan WL, Serafin E and Chamoles NA: An unexpected affected female patient in a classical Lesch-Nyhan family. Mol Genet Metab. 69:263–268. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Sebesta I, Stiburkova B, Dvorakova L, Hrebicek M, Minks J, Stolnaja L, Vernerova Z and Rychlik I: Unusual presentation of Kelley-seegmiller syndrome. Nucleosides Nucleotides Nucleic Acids. 27:648–655. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Aral B, de Saint Basile G, Al-Garawi S, Kamoun P and Ceballos-Picot I: Novel nonsense mutation in the hypoxanthine guanine phosphoribosyltransferase gene and nonrandom X-inactivation causing Lesch-Nyhan syndrome in a female patient. Hum Mutat. 7:52–58. 1996.PubMed/NCBI View Article : Google Scholar | |
|
AlBakheet A, AlQudairy H, Alkhalifah J, Almoaily S, Kaya N and Rahbeeni Z: Detailed genetic and clinical analysis of a novel de novo variant in HPRT1: Case report of a female patient from Saudi Arabia with Lesch-Nyhan syndrome. Front Genet. 13(1044936)2022.PubMed/NCBI View Article : Google Scholar | |
|
Hooft C, Van Nevel C and De Schaepdryver AF: Hyperuricosuric encephalopathy without hyperuricaemia. Arch Dis Child. 43:734–737. 1968.PubMed/NCBI View Article : Google Scholar | |
|
Sekine M, Fujiwara M, Okamoto K, Ichida K, Nagata K, Hille R and Nishino T: Significance and amplification methods of the purine salvage pathway in human brain cells. J Biol Chem. 300(107524)2024.PubMed/NCBI View Article : Google Scholar | |
|
Guibinga GH, Murray F, Barron N, Pandori W and Hrustanovic G: Deficiency of the purine metabolic gene HPRT dysregulates microRNA-17 family cluster and guanine-based cellular functions: A role for EPAC in Lesch-Nyhan syndrome. Hum Mol Genet. 22:4502–4515. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Lopez JM, Outtrim EL, Fu R, Sutcliffe DJ, Torres RJ and Jinnah HA: Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan disease. Proc Natl Acad Sci USA. 117:12071–12079. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Saito Y and Takashima S: Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain Dev. 22 (Suppl 1):S122–S131. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Bell S, Kolobova I, Crapper L and Ernst C: Lesch-Nyhan syndrome: Models, theories, and therapies. Mol Syndromol. 7:302–311. 2016.PubMed/NCBI View Article : Google Scholar | |
|
van der Zee SP, Schretlen ED and Monnens LA: Megaloblastic anaemia in the Lesch-Nyhan syndrome. Lancet. 1(1427)1968.PubMed/NCBI View Article : Google Scholar | |
|
McKeran RO: Factors in the pathogenesis of the brain damage and anaemia in the Lesch-Nyhan syndrome. Ciba Found Symp. 83–96. 1977.PubMed/NCBI View Article : Google Scholar : doi: 10.1002/9780470720301.ch6. | |
|
Nemkov T, Sun K, Reisz JA, Song A, Yoshida T, Dunham A, Wither MJ, Francis RO, Roach RC, Dzieciatkowska M, et al: Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage. Haematologica. 103:361–372. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Laróvere LE, Escuredo E, Becerra A and Dodelson de Kremer R: Lesch-nyhan disease and its variants: Phenotypic and mutation spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency in argentine patients. J Inborn Errors Metab: 9, 2021 doi:10.1590/2326-4594-jiems-2020-0027. | |
|
Saugstad OD: Hypoxanthine as a measurement of hypoxia. Pediatr Res. 9:158–161. 1975.PubMed/NCBI View Article : Google Scholar | |
|
Saugstad OD: Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatr Res. 23:143–150. 1988.PubMed/NCBI View Article : Google Scholar | |
|
Roussel C, Morel A, Dussiot M, Marin M, Colard M, Fricot-Monsinjon A, Martinez A, Chambrion C, Henry B, Casimir M, et al: Rapid clearance of storage-induced microerythrocytes alters transfusion recovery. Blood. 137:2285–2298. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ceballos-Picot I, Mockel L, Potier MC, Dauphinot L, Shirley TL, Torero-Ibad R, Fuchs J and Jinnah HA: Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: Implications for Lesch-Nyhan disease pathogenesis. Hum Mol Genet. 18:2317–2327. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Lewers JC, Ceballos-Picot I, Shirley TL, Mockel L, Egami K and Jinnah HA: Consequences of impaired purine recycling in dopaminergic neurons. Neuroscience. 152:761–772. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Mastrangelo L, Kim JE, Miyanohara A, Kang TH and Friedmann T: Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase. Proc Natl Acad Sci USA. 109:3377–3382. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cuttler K, Hassan M, Carr J, Cloete R and Bardien S: Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders. Open Biol. 11(210091)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ghaffar A, Akhter T, Stromme P, Misceo D, Khan A, Frengen E, Umair M, Isidor B, Cogné B, Khan AA, et al: Variants of NAV3, a neuronal morphogenesis protein, cause intellectual disability, developmental delay, and microcephaly. Commun Biol. 7(831)2024.PubMed/NCBI View Article : Google Scholar | |
|
Ignacio DA, Babikian T, Dennis EL, Bickart KC, Choe M, Snyder AR, Brown A, Giza CC and Asarnow RF: The neurocognitive correlates of DTI indicators of white matter disorganization in pediatric moderate-to-severe traumatic brain injury. Front Hum Neurosci. 18(1470710)2024.PubMed/NCBI View Article : Google Scholar | |
|
Guibinga GH, Hrustanovic G, Bouic K, Jinnah HA and Friedmann T: MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: Clues for Lesch-Nyhan disease? Hum Mol Genet. 21:609–622. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Kang TH, Park Y, Bader JS and Friedmann T: The housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT) regulates multiple developmental and metabolic pathways of murine embryonic stem cell neuronal differentiation. PLoS One. 8(e74967)2013.PubMed/NCBI View Article : Google Scholar | |
|
Guibinga GH: MicroRNAs: Tools of mechanistic insights and biological therapeutics discovery for the rare neurogenetic syndrome Lesch-Nyhan disease (LND). Adv Genet. 90:103–131. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Sutcliffe DJ, Dinasarapu AR, Visser JE, Hoed JD, Seifar F, Joshi P, Ceballos-Picot I, Sardar T, Hess EJ, Sun YV, et al: Induced pluripotent stem cells from subjects with Lesch-Nyhan disease. Sci Rep. 11(8523)2021.PubMed/NCBI View Article : Google Scholar | |
|
Bortolotti M, Polito L, Battelli MG and Bolognesi A: Xanthine oxidoreductase: One enzyme for multiple physiological tasks. Redox Biol. 41(101882)2021.PubMed/NCBI View Article : Google Scholar | |
|
Abramov AY, Scorziello A and Duchen MR: Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci. 27:1129–1138. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Pinto CS and Seifert R: Decreased GTP-stimulated adenylyl cyclase activity in HPRT-deficient human and mouse fibroblast and rat B103 neuroblastoma cell membranes. J Neurochem. 96:454–459. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Gray M, Nash KR and Yao Y: Adenylyl cyclase 2 expression and function in neurological diseases. CNS Neurosci Ther. 30(e14880)2024.PubMed/NCBI View Article : Google Scholar | |
|
Arhakis A, Topouzelis N, Kotsiomiti E and Kotsanos N: Effective treatment of self-injurious oral trauma in Lesch-Nyhan syndrome: A case report. Dent Traumatol. 26:496–500. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Lee J, Lee E, Shin J, Kim S and Jeong T: Semi-fixed lip bumper in lesch-nyhan syndrome: An interim treatment modality. J Korean Acad Pediatr Dent. 47:93–98. 2020. | |
|
Dabrowski E, Smathers SA, Ralstrom CS, Nigro MA and Leleszi JP: Botulinum toxin as a novel treatment for self-mutilation in Lesch-Nyhan syndrome. Dev Med Child Neurol. 47:636–639. 2005.PubMed/NCBI | |
|
Garcia-Romero MDM, Torres RJ, Garcia-Puig J and Pascual-Pascual SI: Safety and efficacy of botulinum toxin in the treatment of Self-biting behavior in Lesch-nyhan disease. Pediatr Neurol. 127:6–10. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Gottle M, Prudente CN, Fu R, Sutcliffe D, Pang H, Cooper D, Veledar E, Glass JD, Gearing M, Visser JE and Jinnah HA: Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease. Ann Neurol. 76:95–107. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN and Fox IH: Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med. 305:1106–1111. 1981.PubMed/NCBI View Article : Google Scholar | |
|
Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF, Ravert HT, Yaster M, Evans A, Rousset O, et al: Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA. 93:5539–5543. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Visser JE, Schretlen DJ, Bloem BR and Jinnah HA: Levodopa is not a useful treatment for Lesch-Nyhan disease. Mov Disord. 26:746–749. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Jankovic J, Caskey TC, Stout JT and Butler IJ: Lesch-Nyhan syndrome: A study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol. 23:466–469. 1988.PubMed/NCBI View Article : Google Scholar | |
|
Watts RW, Spellacy E, Gibbs DA, Allsop J, McKeran RO and Slavin GE: Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the Neurological manifestations. Q J Med. 51:43–78. 1982.PubMed/NCBI | |
|
Montero C, Smolenski RT, Duley JA and Simmonds HA: S-adenosylmethionine increases erythrocyte ATP in vitro by a route independent of adenosine kinase. Biochem Pharmacol. 40:2617–2623. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Glick N: Dramatic reduction in self-injury in Lesch-Nyhan disease following S-adenosylmethionine administration. J Inherit Metab Dis. 29(687)2006.PubMed/NCBI View Article : Google Scholar | |
|
Dolcetta D, Parmigiani P, Salmaso L, Bernardelle R, Cesari U, Andrighetto G, Baschirotto G, Nyhan WL and Hladnik U: Quantitative evaluation of the clinical effects of S-adenosylmethionine on mood and behavior in Lesch-Nyhan patients. Nucleosides Nucleotides Nucleic Acids. 32:174–188. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Elion GB, Benezra FM, Beardmore TD and Kelley WN: Studies with allopurinol in patients with impaired renal function. Adv Exp Med Biol. 122A:263–267. 1980.PubMed/NCBI View Article : Google Scholar | |
|
Daudon M: Crystalluria. Nephrol Ther: 174-190, 2015 (In French). | |
|
Sriranganathan MK, Vinik O, Pardo Pardo J, Bombardier C and Edwards CJ: Interventions for tophi in gout. Cochrane Database Syst Rev. 8(CD010069)2021.PubMed/NCBI View Article : Google Scholar | |
|
Greene ML, Fujimoto WY and Seegmiller JE: Urinary xanthine stones-a rare complication of allopurinol therapy. N Engl J Med. 280:426–427. 1969.PubMed/NCBI View Article : Google Scholar | |
|
Simmonds HA, Reiter S, Davies PM and Cameron JS: Orotidine accumulation in human erythrocytes during allopurinol therapy: Association with high urinary oxypurinol-7-riboside concentrations in renal failure and in the Lesch-Nyhan syndrome. Clin Sci (Lond). 80:191–197. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Krauss JK, Lipsman N, Aziz T, Boutet A, Brown P, Chang JW, Davidson B, Grill WM, Hariz MI, Horn A, et al: Technology of deep brain stimulation: Current status and future directions. Nat Rev Neurol. 17:75–87. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, Matthews K, McIntyre CC, Schlaepfer TE, Schulder M, et al: Deep brain stimulation: Current challenges and future directions. Nat Rev Neurol. 15:148–160. 2019.PubMed/NCBI View Article : Google Scholar | |
|
van Westen M, Rietveld E, Bergfeld IO, de Koning P, Vullink N, Ooms P, Graat I, Liebrand L, van den Munckhof P, Schuurman R and Denys D: Optimizing deep brain stimulation parameters in Obsessive-compulsive disorder. Neuromodulation. 24:307–315. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Pycroft L, Stein J and Aziz T: Deep brain stimulation: An overview of history, methods, and future developments. Brain Neurosci Adv. 2(2398212818816017)2018.PubMed/NCBI View Article : Google Scholar | |
|
McIntyre CC, Savasta M, Kerkerian-Le Goff L and Vitek JL: Uncovering the mechanism(s) of action of deep brain stimulation: Activation, inhibition, or both. Clin Neurophysiol. 115:1239–1248. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Javed N and Cascella M: Neuroanatomy, Globus Pallidus. Publishing ISITIFS, editor, 2023. | |
|
Taira T, Kobayashi T and Hori T: Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus. Case report. J Neurosurg. 98:414–416. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Piedimonte F, Andreani JC, Piedimonte L, Micheli F, Graff P and Bacaro V: Remarkable clinical improvement with bilateral globus pallidus internus deep brain stimulation in a case of Lesch-Nyhan disease: Five-year follow-up. Neuromodulation. 18:118–122. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Llargues-Sistac G, Bonjoch L and Castellvi-Bel S: HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9. Front Cell Dev Biol. 11(1111488)2023.PubMed/NCBI View Article : Google Scholar | |
|
Anzalone AV, Koblan LW and Liu DR: Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 38:824–844. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI and Liu DR: Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature. 551:464–471. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Khasnavis T, Torres RJ, Sommerfeld B, Puig JG, Chipkin R and Jinnah HA: A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease. Mol Genet Metab. 118:160–166. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lauber M, Plecko B, Pfiffner M, Nuoffer JM and Haberle J: The Effect of S-Adenosylmethionine on Self-mutilation in a patient with Lesch-nyhan disease. JIMD Rep. 32:51–57. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Gutierrez C, Pellene A and Micheli F: Botulinum toxin: Treatment of self-mutilation in patients with Lesch-Nyhan syndrome. Clin Neuropharmacol. 31:180–183. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Zecavati N, Santos C and Oyegbile T: Botulinum toxin for the treatment of Extra-pyramidal symptoms of Lesch-nyhan syndrome (P6.252). Neurology. 84(252)2015. | |
|
Gilbert C, Sauer M and Cheng J: Reduction of self-mutilating behavior and improved oromotor function in a patient with Lesch-Nyhan syndrome following botulinum toxin injection: A case report. J Pediatr Rehabil Med. 14:133–136. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Chen BC, Balasubramaniam S, McGown IN, O'Neill JP, Chng GS, Keng WT, Ngu LH and Duley JA: Treatment of Lesch-Nyhan disease with S-adenosylmethionine: Experience with five young Malaysians, including a girl. Brain Dev. 36:593–600. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Pralong E, Pollo C, Coubes P, Bloch J, Roulet E, Tetreault MH, Debatisse D and Villemure JG: Electrophysiological characteristics of limbic and motor globus pallidus internus (GPI) neurons in two cases of Lesch-Nyhan syndrome. Neurophysiol Clin. 35:168–173. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Cif L, Biolsi B, Gavarini S, Saux A, Robles SG, Tancu C, Vasques X and Coubes P: Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease. Mov Disord. 22:2126–2129. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Deon LL, Kalichman MA, Booth CL, Slavin KV and Gaebler-Spira DJ: Pallidal deep-brain stimulation associated with complete remission of self-injurious behaviors in a patient with Lesch-Nyhan syndrome: A case report. J Child Neurol. 27:117–120. 2012.PubMed/NCBI View Article : Google Scholar |
